Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis

Nutrient Modification of the Innate Immune Response

(2010) Eric A. Schwartz et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Prevalence and Trends in Obesity Among US Adults, 1999-2008

(2010) Katherine M. Flegal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The D299G/T399I Toll-Like Receptor 4 Variant Associates with Body and Liver Fat: Results from the TULIP and METSIM Studies

(2010) Peter Weyrich et al.   PLoS One

Toll-like receptors: linking inflammation to metabolism

(2010) A. Christine Könner et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Heart Disease and Stroke Statistics—2009 Update

(2009) et al.   CIRCULATION

Obesity, inflammation, and atherosclerosis

(2009) Viviane Z. Rocha et al.   Nature Reviews Cardiology

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted

(2008) Akio Kawakami et al.   CIRCULATION RESEARCH

Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction

(2008) Yuh Ishikawa et al.   CLINICAL SCIENCE

Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness

(2007) A.H. Schoneveld et al.   ATHEROSCLEROSIS

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids

(2007) Xinyan Liu et al.   ATHEROSCLEROSIS

Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve

(2007) D Versteeg et al.   HEART